Ligand validation:5AIN

QMR: VARENICLINE

QMR is a Ligand Of Interest in 5AIN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AIN_QMR_B_1207	93%	3%	0.085	0.98	2.54	3.8	8	10	0	0	100%	1
5AIN_QMR_A_1207	92%	2%	0.094	0.984	2.57	3.96	9	8	0	0	100%	1
5AIN_QMR_E_1207	91%	2%	0.091	0.978	2.72	3.94	9	10	0	0	100%	1
5AIN_QMR_C_1207	81%	2%	0.121	0.972	2.57	3.88	10	10	1	0	100%	1
5AIN_QMR_D_1207	79%	2%	0.122	0.968	2.56	3.96	9	10	0	0	100%	1
4AFT_QMR_A_301	42%	20%	0.26	0.98	1.63	1.72	2	5	1	0	100%	1
4AFG_QMR_C_1214	90%	6%	0.087	0.97	3.17	2.01	10	6	2	0	100%	1
7S7X_QMR_A_301	82%	1%	0.103	0.959	5.23	3.04	14	8	0	0	100%	1
7S7T_QMR_A_601	34%	1%	0.261	0.949	5.46	3.25	13	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.